Our study delineates the interplay between TMCO1 and CALR, elucidates their association with the pathological characteristics and prognostic indicators of prostate cancer, and lays a theoretical groundwork for the development of targeted therapeutic interventions. This evidence concerns the gene TMCO1 and prostate carcinoma.